Q3 2024 |
16 |
$55.7M |
+$16.1M |
-$4.64M |
+$11.5M |
NVGS, AEM, SPY, BELFB, EPSN
|
13F-HR |
11/14/2024, 02:59 PM |
Q2 2024 |
11 |
$40.9M |
+$4.13M |
-$20.7M |
-$16.6M |
NVGS, AEM, NEM, EPSN, BELFB
|
13F-HR |
8/13/2024, 02:54 PM |
Q1 2024 |
16 |
$56.1M |
+$19.3M |
-$9.17M |
+$10.2M |
NVGS, AEM, EPSN, PBF, VLO
|
13F-HR |
5/14/2024, 02:36 PM |
Q4 2023 |
15 |
$43.6M |
+$14.9M |
-$3.49M |
+$11.4M |
NVGS, AEM, EPSN, UBS, ECVT
|
13F-HR |
2/14/2024, 11:31 AM |
Q3 2023 |
10 |
$30.5M |
+$3.63M |
-$22.1M |
-$18.4M |
NVGS, AEM, EPSN, IRIX, AR
|
13F-HR |
11/14/2023, 01:21 PM |
Q2 2023 |
13 |
$48.9M |
+$9.77M |
-$10.8M |
-$1M |
NVGS, AEM, URI, CF, EPSN
|
13F-HR |
8/14/2023, 11:53 AM |
Q1 2023 |
11 |
$48.1M |
+$11.6M |
-$18.2M |
-$6.66M |
NVGS, AEM, URI, EPSN, ALSN
|
13F-HR |
5/15/2023, 12:16 PM |
Q4 2022 |
17 |
$53.7M |
+$16.1M |
-$17.3M |
-$1.22M |
NVGS, EPSN, APA, URI, AEM
|
13F-HR |
2/13/2023, 01:48 PM |
Q3 2022 |
12 |
$49.5M |
+$15.5M |
-$16.4M |
-$923K |
APA, NVGS, EPSN, SPY, AR
|
13F-HR |
11/14/2022, 02:03 PM |
Q2 2022 |
11 |
$51.2M |
+$6.43M |
-$1.93M |
+$4.49M |
NVGS, AR, AEM, EPSN, APA
|
13F-HR |
8/16/2022, 01:34 PM |
Q1 2022 |
7 |
$53.7M |
+$1.34M |
-$22M |
-$20.7M |
NVGS, AEM, APA, AR, EPSN
|
13F-HR |
5/16/2022, 12:33 PM |
Q4 2021 |
10 |
$62.5M |
+$14.4M |
-$40.3M |
-$25.9M |
SPY, NVGS, AEM, EPSN, APA
|
13F-HR |
2/14/2022, 04:08 PM |
Q3 2021 |
17 |
$88.4M |
+$38.8M |
-$21.5M |
+$17.3M |
SPY, NVGS, EPSN, VRS, AR
|
13F-HR |
11/15/2021, 04:01 PM |
Q2 2021 |
16 |
$75.2M |
+$19.2M |
-$20.5M |
-$1.29M |
NVGS, RETA, MLKN, IRIX, EPSN
|
13F-HR |
8/16/2021, 01:06 PM |
Q1 2021 |
11 |
$65.6M |
+$9.14M |
-$9.82M |
-$677K |
NEM, NVGS, RETA, IRIX, EPSN
|
13F-HR |
5/14/2021, 12:42 PM |
Q4 2020 |
10 |
$65M |
+$7.52M |
-$27.1M |
-$19.6M |
RETA, NEM, NVGS, EPSN, BK
|
13F-HR |
2/12/2021, 09:41 AM |
Q3 2020 |
8 |
$74.5M |
+$17.7M |
-$26M |
-$8.27M |
SPY, NEM, RETA, NVGS, GOLD
|
13F-HR |
11/13/2020, 04:07 PM |
Q2 2020 |
10 |
$91M |
+$8.36M |
-$26.8M |
-$18.5M |
RETA, NEM, GOLD, NVGS, ABBV
|
13F-HR |
8/14/2020, 12:05 PM |
Q1 2020 |
13 |
$93.1M |
+$24M |
-$79.8M |
-$55.8M |
RETA, NEM, QQQ, SPY, GOLD
|
13F-HR |
5/15/2020, 10:15 AM |
Q4 2019 |
19 |
$178M |
+$12.9M |
-$10.1M |
+$2.78M |
RETA, HUM, OXY, NEM, NVGS
|
13F-HR |
2/13/2020, 01:28 PM |
Q3 2019 |
21 |
$130M |
+$24.8M |
-$19.6M |
+$5.21M |
RETA, NEM, HUM, ABBV, OXY
|
13F-HR |
11/13/2019, 03:51 PM |
Q2 2019 |
25 |
$130M |
+$42.8M |
-$24.9M |
+$18M |
RETA, HUM, OXY, NEM, NVGS
|
13F-HR |
8/14/2019, 12:10 PM |
Q1 2019 |
30 |
$106M |
+$43.6M |
-$27.4M |
+$16.2M |
RETA, NVGS, NEM, PARR, IRIX
|
13F-HR |
5/14/2019, 12:43 PM |
Q4 2018 |
21 |
$75.3M |
+$18M |
-$9.91M |
+$8.09M |
RETA, NVGS, JPM, AGN, IRIX
|
13F-HR |
2/13/2019, 01:40 PM |
Q3 2018 |
19 |
$87.7M |
+$9.2M |
-$15.2M |
-$6.04M |
RETA, NVGS, IRIX, AGN, PARR
|
13F-HR |
11/14/2018, 01:01 PM |
Q2 2018 |
23 |
$75.3M |
+$17.7M |
-$17.6M |
+$166K |
NVGS, RETA, IRIX, AGN, QADA
|
13F-HR |
8/14/2018, 02:26 PM |
Q1 2018 |
16 |
$68.6M |
+$12.5M |
-$59.7M |
-$47.2M |
NVGS, IRIX, AGN, OXY, RETA
|
13F-HR |
5/15/2018, 04:08 PM |
Q4 2017 |
20 |
$120M |
+$31.9M |
-$30.7M |
+$1.2M |
SPY, C, NVGS, DAL, OXY
|
13F-HR |
2/13/2018, 03:14 PM |
Q3 2017 |
23 |
$117M |
+$33.9M |
-$15.3M |
+$18.6M |
NVGS, IRIX, SPY, C, PARR
|
13F-HR |
11/13/2017, 01:13 PM |
Q2 2017 |
15 |
$85.6M |
+$29.7M |
-$27.2M |
+$2.44M |
SPY, IRIX, PARR, NVGS, C
|
13F-HR |
8/14/2017, 11:43 AM |
Q1 2017 |
20 |
$93M |
+$20.4M |
-$5.38M |
+$15M |
NVGS, IRIX, PARR, MYL, ESXB
|
13F-HR |
5/15/2017, 01:13 PM |
Q4 2016 |
16 |
$75.2M |
+$9.29M |
-$23M |
-$13.7M |
IRIX, NVGS, PARR, ESXB, RETA
|
13F-HR |
2/13/2017, 03:38 PM |
Q3 2016 |
15 |
$86.5M |
+$8.35M |
-$21.3M |
-$12.9M |
IRIX, PARR, BSFT, NVGS, ESXB
|
13F-HR |
11/14/2016, 04:04 PM |
Q2 2016 |
18 |
$102M |
+$25.8M |
-$41.9M |
-$16.1M |
IRIX, YHOO, PARR, NVGS, BSFT
|
13F-HR |
8/15/2016, 11:40 AM |
Q1 2016 |
17 |
$119M |
+$24.4M |
-$26.2M |
-$1.82M |
CSCD, NVGS, PARR, IRIX, YHOO
|
13F-HR |
5/13/2016, 11:48 AM |
Q4 2015 |
18 |
$117M |
+$16.6M |
-$3.93M |
+$12.6M |
PARR, CSCD, DAL, IRIX, NVGS
|
13F-HR |
2/12/2016, 06:01 PM |
Q3 2015 |
19 |
$93.6M |
+$14.5M |
-$26.8M |
-$12.2M |
PARR, CSCD, DAL, NVGS, IRIX
|
13F-HR |
11/13/2015, 05:12 PM |
Q2 2015 |
23 |
$116M |
+$29.3M |
-$26.1M |
+$3.17M |
MET, CSCD, NVGS, ISCA, DAL
|
13F-HR |
8/13/2015, 04:13 PM |
Q1 2015 |
16 |
$114M |
+$35.1M |
-$81.5M |
-$46.5M |
NVGS, CSCD, PARR, DAL, C
|
13F-HR |
5/14/2015, 06:08 PM |
Q4 2014 |
19 |
$158M |
+$24M |
-$16.2M |
+$7.77M |
AAL, C, BAC, CSCD, HON
|
13F-HR |
2/13/2015, 07:49 AM |
Q3 2014 |
17 |
$135M |
+$30.4M |
-$13.2M |
+$17.3M |
C, AAL, BAC, HON, GLD
|
13F-HR |
11/14/2014, 01:15 PM |
Q2 2014 |
20 |
$125M |
+$47.1M |
-$22.1M |
+$25M |
AAL, GLD, HON, MET, BAC
|
13F-HR |
8/13/2014, 03:45 PM |
Q1 2014 |
16 |
$100M |
+$10M |
-$76.8M |
-$66.8M |
AAL, WPX, MET, UAL, IRIX
|
13F-HR |
5/12/2014, 06:32 PM |
Q4 2013 |
20 |
$149M |
$0 |
$0 |
|
SPNC, UAL, MET, AAL, LM
|
13F-HR |
2/14/2014, 02:12 PM |